435 related articles for article (PubMed ID: 18005984)
1. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
2. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
[TBL] [Abstract][Full Text] [Related]
3. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
[TBL] [Abstract][Full Text] [Related]
4. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
[TBL] [Abstract][Full Text] [Related]
5. Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
Martins M; Pluvinage B; Li de la Sierra-Gallay I; Barbault F; Dairou J; Dupret JM; Rodrigues-Lima F
J Mol Biol; 2008 Nov; 383(3):549-60. PubMed ID: 18778714
[TBL] [Abstract][Full Text] [Related]
6. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.
Goodfellow GH; Dupret JM; Grant DM
Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727
[TBL] [Abstract][Full Text] [Related]
7. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
8. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
10. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
Wang H; Liu L; Hanna PE; Wagner CR
Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
[TBL] [Abstract][Full Text] [Related]
11. Gene cloning and characterization of arylamine N-acetyltransferase from Bacillus cereus strain 10-L-2.
Takenaka S; Cheng M; Mulyono ; Koshiya A; Murakami S; Aoki K
J Biosci Bioeng; 2009 Jan; 107(1):27-32. PubMed ID: 19147105
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
[TBL] [Abstract][Full Text] [Related]
13. Arylamine N-acetyltransferases.
Sim E; Westwood I; Fullam E
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):169-84. PubMed ID: 17428149
[TBL] [Abstract][Full Text] [Related]
14. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop.
Rodrigues-Lima F; Dupret JM
Biochem Biophys Res Commun; 2002 Feb; 291(1):116-23. PubMed ID: 11829470
[TBL] [Abstract][Full Text] [Related]
15. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
Brooke EW; Davies SG; Mulvaney AW; Pompeo F; Sim E; Vickers RJ
Bioorg Med Chem; 2003 Apr; 11(7):1227-34. PubMed ID: 12628650
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of an arylamine N-acetyltransferase from the pathogen Mycobacterium abscessus: differences from other mycobacterial isoforms and implications for selective inhibition.
Cocaign A; Kubiak X; Xu X; Garnier G; Li de la Sierra-Gallay I; Chi-Bui L; Dairou J; Busi F; Abuhammad A; Haouz A; Dupret JM; Herrmann JL; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):3066-79. PubMed ID: 25372695
[TBL] [Abstract][Full Text] [Related]
17. The conserved glycine/alanine residue of the active-site loop containing the putative acetylCoA-binding motif is essential for the overall structural integrity of Mesorhizobium loti arylamine N-acetyltransferase 1.
Atmane N; Dairou J; Flatters D; Martins M; Pluvinage B; Derreumaux P; Dupret JM; Rodrigues-Lima F
Biochem Biophys Res Commun; 2007 Sep; 361(1):256-62. PubMed ID: 17658468
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of NAT: structural aspects.
Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
[TBL] [Abstract][Full Text] [Related]
19. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism.
Xu Y; Nakajima Y; Ito K; Zheng H; Oyama H; Heiser U; Hoffmann T; Gärtner UT; Demuth HU; Yoshimoto T
J Mol Biol; 2008 Jan; 375(3):708-19. PubMed ID: 18042490
[TBL] [Abstract][Full Text] [Related]
20. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.
Zhang N; Liu L; Liu F; Wagner CR; Hanna PE; Walters KJ
J Mol Biol; 2006 Oct; 363(1):188-200. PubMed ID: 16959263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]